Cartesian Therapeutics
RNAC
#6926
Rank
$0.43 B
Marketcap
$17.00
Share price
2.29%
Change (1 day)
-51.15%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -$0.25 Billion USD

According to Cartesian Therapeutics's latest financial reports the company's current earnings are $54.1 Million USD. In 2023 the company made an earning of -$0.24 Billion USD a decrease over its 2022 earnings that were of $37.8 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.25 Billion4.87%
2023 -$0.24 Billion-724%
2022 $37.8 M-649.67%
2021 -$6.88 Million-89.78%
2020 -$67.32 Million25.06%
2019 -$53.84 Million-15.68%
2018 -$63.85 Million-0.43%
2017 -$64.12 Million83.41%
2016 -$34.96 Million44.3%
2015 -$24.23 Million